Cargando…
Graded coronavirus disease 2019 vaccine administration: A safe alternative to vaccine avoidance
Autores principales: | Pitlick, Mitchell M., Gonzalez-Estrada, Alexei, Park, Miguel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894737/ https://www.ncbi.nlm.nih.gov/pubmed/35257875 http://dx.doi.org/10.1016/j.anai.2022.02.024 |
Ejemplares similares
-
Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
por: Pitlick, Mitchell M., et al.
Publicado: (2021) -
Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination
por: Dages, Kelley N., et al.
Publicado: (2021) -
TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING
por: Hamel, B., et al.
Publicado: (2022) -
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report
por: Pitlick, Mitchell M., et al.
Publicado: (2021) -
Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions
por: Pitlick, Mitchell M., et al.
Publicado: (2022)